Relay Therapeutics
RLAY
$6.66
Share price
2.15%
Change (1 day)
-41.78%
Change (1 year)
Categories
Relay Therapeutics (RLAY) - Cash on Hand
Cash on Hand as of December 2023 : $0.75 B
According to Relay Therapeutics's latest financial reports the company has $0.75 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Relay Therapeutics - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.75 B | -24.91% |
| 2022-12-31 | $0.99 B | 4.26% |
| 2021-12-31 | $0.95 B | 41.3% |
| 2020-12-31 | $0.67 B | 90.57% |
| 2019-12-31 | $0.35 B | -15.58% |
| 2018-12-31 | $0.42 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -72.24% | 🇺🇸 USA |